Generated by All in One SEO v4.9.10, this is an llms.txt file, used by LLMs to index the site. # Forum for Innovative Regenerative Medicine ## 投稿 - [Report: General Meeting 2026](https://firm.or.jp/en/reports/2067/) - [Report: The 9th APACRM](https://firm.or.jp/en/reports/international-r/2023/) - [Report: RMVF#18](https://firm.or.jp/en/reports/rmit-r/1979/) - [Report: Cell & Gene Meeting on the Mesa 2025（CGMOM 2025）](https://firm.or.jp/en/reports/international-r/1960/) - [Report III: Regenerative Medicine Japan 2025](https://firm.or.jp/en/reports/public-r/1939/) - [Report I: Regenerative Medicine Japan 2025](https://firm.or.jp/en/reports/public-r/1917/) - [Report II: Regenerative Medicine Japan 2025](https://firm.or.jp/en/reports/public-r/1929/) - [FIRM brochure 2025](https://firm.or.jp/en/reports/1899/) - [Notice: Regarding change of Chairperson and Representative Director](https://firm.or.jp/en/reports/1691/) - [FIRM List of Products with Certification of Suitability for Ancillary Material has been updated.](https://firm.or.jp/en/reports/1677/) - [FIRM List of Products with Certification of Suitability for Ancillary Material](https://firm.or.jp/en/reports/support-r/1664/) - [Report：8th APACRM](https://firm.or.jp/en/reports/international-r/1640/) - [Report: The 8th Forum for Supporting Start-ups was held on the 8th of November.](https://firm.or.jp/en/reports/rmit-r/1561/) - [Report part I: Bio Japan 2024 -FIRM Sponsored Seminars-](https://firm.or.jp/en/reports/public-r/1511/) - [Report: FIRM’s entreprenership academy 2024](https://firm.or.jp/en/reports/rmit-r/1544/) - [Report: FIRM received Japan Bioindustry Special Award 2024](https://firm.or.jp/en/reports/standardization-r/1551/) - [Report part II: Bio Japan 2024 -FIRM Exhibition Booth-　](https://firm.or.jp/en/reports/public-r/1523/) - [Report: Cell & Gene Meeting on the Mesa 2024（CGMOM 2024）](https://firm.or.jp/en/reports/international-r/1501/) - [Poseted a new FIRM brochure](https://firm.or.jp/en/reports/1450/) - [1st Venture (startup) booster](https://firm.or.jp/en/reports/rmit-r/1411/) - [53rd Parliamentary league (Giren) on regenerative medicine](https://firm.or.jp/en/reports/1406/) - [First issue of FIRM Mark Certification](https://firm.or.jp/en/reports/1394/) - [Report: 7th APACRM on the 25th of April](https://firm.or.jp/en/reports/1390/) - [Regenerative Medicine and Cell & Gene Therapy in Japan: Information Materials for CDMO and Related Companies](https://firm.or.jp/en/reports/specific-r/1353/) - [Report: Participation in Mesa 2023](https://firm.or.jp/en/reports/international-r/1311/) - [Report: Participation in RMAF 2023, South Korea](https://firm.or.jp/en/reports/international-r/1304/) - [Notice: FIRM startup/Private company map released](https://firm.or.jp/en/reports/rmit-r/1291/) - [Notice regarding change of Chairperson and Representative Director](https://firm.or.jp/en/reports/1161/) - [2022.10.10 The white paper "Cell and Gene Therapies" was opened to public at the "ECONOMIST IMPACT" web site.](https://firm.or.jp/en/public/1128/) - [Chairperson Hata gave a presentation on International Symposium on Healthcare between Taiwan and Japan](https://firm.or.jp/en/public/1112/) - [Contribution: Meeting summary to Cytotherapy by the 4th APACRM 2021](https://firm.or.jp/en/reports/international-r/876/) - [Contribution: Article to Cytotherapy by APACRM Working Group2](https://firm.or.jp/en/reports/international-r/1100/) - [Report: BioJapan 2022 and Regenerative Medicine JAPAN 2022](https://firm.or.jp/en/reports/event-r/1067/) - [Report: AusBiotech 2022](https://firm.or.jp/en/reports/international-r/1059/) ## 固定ページ - [Forum for Innovative Regenerative Medicine](https://firm.or.jp/en/) - The Forum for Innovative Regenerative Medicine (FIRM) - [Sitemap​](https://firm.or.jp/en/sitemap/) - [FIRM VISION 2030](https://firm.or.jp/en/about/firm-vision-2030/) - FIRM VISION 2025​ - [Company Info​](https://firm.or.jp/en/about/summary/) - ​FIRM Company Info - [FIRM Startup / Private Company Map](https://firm.or.jp/en/venturemap/) - [A message from ​ the Chairperson](https://firm.or.jp/en/about/greeting/) - A message from ​ the Chairman​ / FIRM - [Ancillary Materials for Regenerative Medical Products](https://firm.or.jp/en/amlist/) - [Access](https://firm.or.jp/en/about/access/) - [National and international regenerative medicine trends](https://firm.or.jp/en/home-and-abroad/) - [Organization Chart](https://firm.or.jp/en/about/chart/) - ​FIRM Organization Chart - [Overview​ FIRM History​](https://firm.or.jp/en/about/history/) - ​ Overview​ FIRM History​ - [About FIRM​](https://firm.or.jp/en/about/) - About The Forum for Innovative Regenerative Medicine (FIRM) - [Contact us](https://firm.or.jp/en/contact/) - [APACRM](https://firm.or.jp/en/apacrm/) - Asia Partnership Conference of Regenerative Medicine Associations (APACRM) ## FIRM Startup / Private Company Map - [Otolaryngology
Pre-Clinical](https://firm.or.jp/en/venture-map/otolaryngologypre-clinical) - [Immunity
Pre-Clinical](https://firm.or.jp/en/venture-map/immunitypre-clinical) - [Blood
Pre-Clinical](https://firm.or.jp/en/venture-map/bloodpre-clinical) - [Musculoskeletal
Basic Research](https://firm.or.jp/en/venture-map/musculoskeletalbasic-research) - [Ophthalmology
Clinical Trial (Phase III)](https://firm.or.jp/en/venture-map/ophthalmologyclinical-trial-phase-iii) - [Manufacturing equipment](https://firm.or.jp/en/venture-map/manufacturing-_equipment) - [CDMO](https://firm.or.jp/en/venture-map/cdmo) - [Cell banking](https://firm.or.jp/en/venture-map/cell-banking) - [Culture medium](https://firm.or.jp/en/venture-map/culture_medium) - [Cell / Viral vector manufacturing technology](https://firm.or.jp/en/venture-map/cell-viral-vector-manufacturing-technology) - [Logistics](https://firm.or.jp/en/venture-map/logistics) - [Facilities](https://firm.or.jp/en/venture-map/facilities) - [Reagents](https://firm.or.jp/en/venture-map/reagents) - [Cells](https://firm.or.jp/en/venture-map/cells) - [Platform Technologies](https://firm.or.jp/en/venture-map/platform-technologies) - [Immunity
Clinical Trial (Phase II)](https://firm.or.jp/en/venture-map/immunityclinical-trial-phase-ii) - [Others
Clinical Trial (Phase II)](https://firm.or.jp/en/venture-map/othersclinical-trial-phase-ii) - [Others
Clinical Trial (Phase I)](https://firm.or.jp/en/venture-map/othersclinical-trial-phase-i) - [Musculoskeletal
Pre-Clinical](https://firm.or.jp/en/venture-map/musculoskeletalpre-clinical) - [Respiratory
Clinical Trial (Phase II)](https://firm.or.jp/en/venture-map/respiratoryclinical-trial-phase-ii) - [Immunity
Clinical Trial (Phase I)](https://firm.or.jp/en/venture-map/immunityclinical-trial-phase-i) - [Digestive organ
Clinical Trial (Phase III)](https://firm.or.jp/en/venture-map/digestive-organclinical-trial-phase-iii) - [Digestive organ
Pre-Clinical](https://firm.or.jp/en/venture-map/digestive-organpre-clinical) - [Urogenital
Clinical Trial (Phase I)](https://firm.or.jp/en/venture-map/urogenitalclinical-trial-phase-i) - [Cardiovascular
Clinical Trial (Phase III)](https://firm.or.jp/en/venture-map/cardiovascularclinical-trial-phase-iii) - [Cardiovascular
Clinical Trial (Phase II)](https://firm.or.jp/en/venture-map/cardiovascularclinical-trial-phase-ii) - [Cardiovascular
Clinical Trial (Phase I)](https://firm.or.jp/en/venture-map/cardiovascularclinical-trial-phase-i) - [Cardiovascular
Pre-Clinical](https://firm.or.jp/en/venture-map/cardiovascularpre-clinical) - [Central nervous system
Clinical Trial (Phase I)](https://firm.or.jp/en/venture-map/central-nervous-systemclinical-trial-phase-i) - [Musculoskeletal
Clinical Trial (Phase III)](https://firm.or.jp/en/venture-map/musculoskeletalclinical-trial-phase-iii) - [Ophthalmology
Clinical Trial (Phase I)](https://firm.or.jp/en/venture-map/ophthalmologyclinical-trial-phase-i) - [Central nervous system
Review](https://firm.or.jp/en/venture-map/central-nervous-systemreview) - [Central nervous system
Pre-Clinical](https://firm.or.jp/en/venture-map/central-nervous-systempre-clinical) - [Central nervous system
Clinical Trial (Phase II)](https://firm.or.jp/en/venture-map/central-nervous-systemclinical-trial-phase-ii) - [Endocrine / Metabolism
Pre-Clinical](https://firm.or.jp/en/venture-map/endocrine-metabolismpre-clinical) - [Others
Clinical Trial (Phase III)](https://firm.or.jp/en/venture-map/othersclinical-trial-phase-iii) - [Ophthalmology
Clinical Trial (Phase II)](https://firm.or.jp/en/venture-map/ophthalmologyclinical-trial-phase-ii) - [Blood
Clinical Trial (Phase II)](https://firm.or.jp/en/venture-map/bloodclinical-trial-phase-ii) ## Cdmo List - [I Peace, Inc.](https://firm.or.jp/en/cdmo/i-peace-inc) - [Takara Bio Inc.](https://firm.or.jp/en/cdmo/takara-bio-inc) - [Cellafa Bioscience Inc.](https://firm.or.jp/en/cdmo/cellafa-bioscience-inc) - [Minaris Advanced Therapies Co., Ltd.](https://firm.or.jp/en/cdmo/minaris-advanced-therapies-co-ltd) - [ARCALIS, Inc.](https://firm.or.jp/en/cdmo/arcalis-inc) - [S-RACMO Co.,Ltd.](https://firm.or.jp/en/cdmo/s-racmo-co-ltd) - [ROHTO Pharmaceutical Co., Ltd.](https://firm.or.jp/en/cdmo/rohto-pharmaceutical-co-ltd) - [Cell Resources Corporation](https://firm.or.jp/en/cdmo/cell-resources-corporation) - [Cellab Healthcare Service CO.,LTD.](https://firm.or.jp/en/cdmo/cellab-healthcare-service-co-ltd) - [U-Medico Inc.](https://firm.or.jp/en/cdmo/u-medico-inc) - [TFBS Bioscience, LLC](https://firm.or.jp/en/cdmo/tfbs-bioscience-llc) - [TEIJIN REGENET CO., LTD.](https://firm.or.jp/en/cdmo/teijin-regenet-co-ltd) - [Synplogen Co., Ltd.](https://firm.or.jp/en/cdmo/synplogen-co-ltd) - [TAIYO Pharma Tech Co., Ltd.](https://firm.or.jp/en/cdmo/taiyo-pharma-tech-co-ltd) - [REPROCELL Inc.](https://firm.or.jp/en/cdmo/reprocell-inc) - [Ricoh Biosciences, K.K.](https://firm.or.jp/en/cdmo/ricoh-biosciences-k-k) - [Rohto Cell Factory Tokyo Co., Ltd.](https://firm.or.jp/en/cdmo/rohto-cell-factory-tokyo-co-ltd) - [PharmaBio Corporation](https://firm.or.jp/en/cdmo/pharmabio-corporation) - [Nikon CeLL innovation Co., Ltd.](https://firm.or.jp/en/cdmo/nikon-cell-innovation-co-ltd) - [MicroBiopharm Japan Co., Ltd.](https://firm.or.jp/en/cdmo/microbiopharm-japan-co-ltd) - [MediRidge Co.,Ltd.](https://firm.or.jp/en/cdmo/mediridge-co-ltd) - [MEDINET Co., Ltd.](https://firm.or.jp/en/cdmo/medinet-co-ltd) - [Kohjin Bio Co., Ltd.](https://firm.or.jp/en/cdmo/kohjin-bio-co-ltd) - [JCR Pharmaceuticals Co., Ltd.](https://firm.or.jp/en/cdmo/jcr-pharmaceuticals-co-ltd) - [Japan Tissue Engineering Co., Ltd. (J-TEC)](https://firm.or.jp/en/cdmo/japan-tissue-engineering-co-ltd-j-tec) - [Interstem Co., Ltd.](https://firm.or.jp/en/cdmo/interstem-co-ltd) - [ID Pharma Co., Ltd](https://firm.or.jp/en/cdmo/id-pharma-co-ltd) - [H.U.Cells, Inc.](https://firm.or.jp/en/cdmo/h-u-cells-inc) - [FUJIFILM Toyama Chemical Co., Ltd.](https://firm.or.jp/en/cdmo/fujifilm-toyama-chemical-co-ltd) - [Cyto-Facto Inc.](https://firm.or.jp/en/cdmo/cyto-facto-inc) - [CellSeed Inc.](https://firm.or.jp/en/cdmo/cellseed-inc) - [AGC Inc./AGC Biologics](https://firm.or.jp/en/cdmo/agc-inc) ## カテゴリー - [Activity Reports​](https://firm.or.jp/en/reports/) - [International Affairs Committee](https://firm.or.jp/en/reports/international-r/) - [Public Affairs Committee](https://firm.or.jp/en/reports/public-r/) - [Standardization Committee](https://firm.or.jp/en/reports/standardization-r/) - [Supporting Industries Committee](https://firm.or.jp/en/reports/support-r/) - [Venture Establishment / Promotion Committee](https://firm.or.jp/en/reports/rmit-r/) - [Public Comment](https://firm.or.jp/en/public/) - [Event report](https://firm.or.jp/en/reports/event-r/) - [Specific Processed Cells Committee](https://firm.or.jp/en/reports/specific-r/) ## 会員紹介カテゴリー - [Regular Members](https://firm.or.jp/en/intro_cat/regular/) - [Special Members](https://firm.or.jp/en/intro_cat/special/) - [Supporting Members](https://firm.or.jp/en/intro_cat/supporting/) - [Supporting Members (Individual)](https://firm.or.jp/en/intro_cat/individual/) - [Honorary Member (Individual)](https://firm.or.jp/en/intro_cat/honorary/) ## 会員紹介タグ - [Chemistry・Materials](https://firm.or.jp/en/intro_tag/materials/) - [CMO/CDMO](https://firm.or.jp/en/intro_tag/cmo/) - [Logistics・Services・Others](https://firm.or.jp/en/intro_tag/others/) - [Machines・Equipment](https://firm.or.jp/en/intro_tag/machines/) - [RegenerativeMedicine・Pharmaceutical](https://firm.or.jp/en/intro_tag/medical/)